جاهز للتشغيل
جاهز للتشغيل
A study published in the journal Nature Immunology indicates that Crohn's disease may not be caused by an overactive immune system as previously thought, but rather by a weakness in the innate immune response within the intestines. The research revealed that activation of the NOD2 gene, which is genetically linked to increased risk of the disease, directs T cells to enhance immune response and protect the gut from inflammation. When the NOD2 pathway is impaired, the immune response is disrupted, leading to the development of chronic inflammation. The study suggests that inflammation in Crohn's may result from a series of immune imbalances, changing the way the disease is understood and highlighting the need to develop therapeutic strategies that target early immune dysfunction rather than focusing solely on treating inflammation after it appears. Although these findings are currently based on animal models, they open new horizons for more targeted treatment and early prevention for Crohn's patients.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading